161 related articles for article (PubMed ID: 28010166)
41. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
[TBL] [Abstract][Full Text] [Related]
42. Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion.
Lee EY; Kaneko S; Jutabha P; Zhang X; Seino S; Jomori T; Anzai N; Miki T
J Endocrinol; 2015 Mar; 224(3):205-14. PubMed ID: 25486965
[TBL] [Abstract][Full Text] [Related]
43. Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
Kuritzky L; Samraj G; Quillen DM
Hosp Pract (1995); 1999 Sep; 34(10):43-6. PubMed ID: 10901748
[No Abstract] [Full Text] [Related]
44. [Drug therapy of type 2 diabetes: insulin sensitizers improve results].
Stadler HJ
Pflege Z; 1999 Nov; 52(11):772-5. PubMed ID: 10788929
[No Abstract] [Full Text] [Related]
45. [Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Sakamoto N; Tajima N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():451-6. PubMed ID: 15779421
[No Abstract] [Full Text] [Related]
46. Changes in α-glucosidase activities along the jejunal-ileal axis of normal rats by the α-glucosidase inhibitor miglitol.
Mochizuki K; Hanai E; Suruga K; Kuranuki S; Goda T
Metabolism; 2010 Oct; 59(10):1442-7. PubMed ID: 20153003
[TBL] [Abstract][Full Text] [Related]
47. Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review.
Kaur N; Kumar V; Nayak SK; Wadhwa P; Kaur P; Sahu SK
Chem Biol Drug Des; 2021 Oct; 98(4):539-560. PubMed ID: 34173346
[TBL] [Abstract][Full Text] [Related]
48. Newer insights into the drug delivery approaches of α-glucosidase inhibitors.
Kumar RV; Sinha VR
Expert Opin Drug Deliv; 2012 Apr; 9(4):403-16. PubMed ID: 22364261
[TBL] [Abstract][Full Text] [Related]
49. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
[TBL] [Abstract][Full Text] [Related]
50. On the potential of acarbose to reduce cardiovascular disease.
Standl E; Theodorakis MJ; Erbach M; Schnell O; Tuomilehto J
Cardiovasc Diabetol; 2014 Apr; 13():81. PubMed ID: 24742256
[TBL] [Abstract][Full Text] [Related]
51. [Adverse effects of alpha-glucosidase inhibitors].
Sakaguchi K; Kasuga M
Nihon Rinsho; 2007 Oct; 65 Suppl 8():183-7. PubMed ID: 18074536
[No Abstract] [Full Text] [Related]
52. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Hamada Y; Nagasaki H; Fuchigami M; Furuta S; Seino Y; Nakamura J; Oiso Y
Metabolism; 2013 May; 62(5):734-42. PubMed ID: 23194643
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol.
Fujita Y; Tamada D; Kozawa J; Kobayashi Y; Sasaki S; Kitamura T; Yasuda T; Maeda N; Otsuki M; Okita K; Iwahashi H; Kaneto H; Funahashi T; Imagawa A; Shimomura I
Intern Med; 2012; 51(18):2581-5. PubMed ID: 22989830
[TBL] [Abstract][Full Text] [Related]
54. Biosynthesis of α-Glucosidase Inhibitors by a Newly Isolated Bacterium, Paenibacillus sp. TKU042 and Its Effect on Reducing Plasma Glucose in a Mouse Model.
Nguyen VB; Nguyen AD; Kuo YH; Wang SL
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28346347
[TBL] [Abstract][Full Text] [Related]
55. An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients.
Eguchi K; Komori T; Saito T; Hoshide S; Kario K
J Electrocardiol; 2018; 51(1):21-26. PubMed ID: 28918212
[TBL] [Abstract][Full Text] [Related]
56. The alpha-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes.
Hasegawa G; Kajiyama S; Tanaka T; Imai S; Kozai H; Fujinami A; Ohta M; Obayashi H; Park H; Nakano K; Tanaka M; Shiraishi E; Fukui M; Yoshikawa T; Nakamura N
Clin Chim Acta; 2008 Apr; 390(1-2):110-4. PubMed ID: 18230353
[TBL] [Abstract][Full Text] [Related]
57. Acarbose: its role in the treatment of diabetes mellitus.
Campbell LK; White JR; Campbell RK
Ann Pharmacother; 1996 Nov; 30(11):1255-62. PubMed ID: 8913408
[TBL] [Abstract][Full Text] [Related]
58. Preventive treatment with acarbose in diabetic reactive hypoglycemia.
Lee A
J Am Med Dir Assoc; 2010 Jun; 11(5):377-8. PubMed ID: 20511106
[No Abstract] [Full Text] [Related]
59. [Combination therapy with insulin and alpha-glucosidase inhibitor].
Watanabe K; Kawamori R
Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
[No Abstract] [Full Text] [Related]
60. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
